Introducing CODE3
Drawing on 12 years of rigorous research and clinical refinement, our patent-pending formula (63/800,093) harnesses Tranexamic Acid, Bakuchiol, and Quercetin to even skin tone, diminish visible signs of aging, and accelerate post-procedure recovery.
CODE3 Early Access Program
CODE3 is available exclusively through our Early Access Program at select plastic surgery practices. Scan your QR code and input your access code received in-office to unlock premium skin care.
Participating Providers
-
Dr. Melinda Costa
2516 Samaritan Dr Suite N, San Jose, CA 95124
Key Ingredients
Tranexamic Acid
Clinically shown to inhibit melanin pathways, reduce dark spots and even skin tone.
Bakuchiol
A plant-based retinol alternative that stimulates collagen production and smooths fine lines without the irritation of retinoids.
Quercetin
Potent antioxidant that calms inflammation and protects skin from environmental stressors.
Key Scientific Articles on Tranexamic Acid for Skincare
Topical Tranexamic Acid as a Promising Treatment for Melasma
Demonstrated that 3% topical TA safely and effectively reduces hyperpigmentation in melasma patients, with significant MASI score improvements over 12 weeks.
Read Full Paper5% Tranexamic Acid vs. 3% Hydroquinone in Melasma: A Randomized Trial
This RCT compared 5% TA solution with 3% hydroquinone cream in Indian skin, showing equivalent MASI reduction but higher patient satisfaction and fewer adverse effects with TA.
Read Full PaperTXA in Melasma Management: Systematic Review & Meta-Analysis
A comprehensive meta-analysis of RCTs confirming that topical and oral TXA significantly improve melasma outcomes with a favorable safety profile.
Read Full PaperTXA for Anti-Aging Benefits
An injectable gel made of hyaluronic acid, niacinamide, and tranexamic acid that, in a study of 49 women, noticeably improved skin hydration, firmness, smoothness, and evenness over 70 days.
Read Full PaperTestimonials
Repurchase CODE3
*Everybody responds a little bit differently to topical products. If you're one of those individuals who notices irritation, we recommend to reduce or stop use.